11:00am Eastern Time (US)

This webinar was recorded and is available to Histiocyte Society members in the Member Portal.

Please Note: This webinar is open to and intended for Medical Professionals only.  
Patients and families are encouraged to connect with the Histiocytosis Association for information on upcoming patient and family-focused webinars.

male silhouette icon

Omar Abdel-Wahab, MD

Title of Presentation: 
Molecular Pathogenesis & Precision Targeting of Histiocytic Neoplasms

Dr. Omar Abdel-Wahab is an Associate Member in the Human Oncology and Pathogenesis Program, an Attending Physician on the Leukemia Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK), and the Director of the Center for Hematologic Malignancies at MSK. His research focuses on understanding the functional implications of somatic mutations found in patients with hematopoietic malignancies with the hopes of improving our understanding of disease biology and develop novel therapies. His research is supported by the National Cancer Institute, National Heart, Lung, and Blood Institutes, the Leukemia & Lymphoma Society, the Dept. of Defense, the American Society of Hematology (ASH), and numerous additional philanthropic organizations (including the Histiocytosis Association and Erdheim-Chester Disease Global Alliance). Dr. Abdel-Wahab's work has been recognized by a 2017 ASCI Seldin Smith Award for Pioneering Research, the 2016 Joanne Levy Memorial Award for Outstanding Achievement from ASH, and a 2016 Pershing Square Sohn Cancer Research Alliance Award.  

Scott Weiss, MD, MSCE, FCCM

Title of Presentation:
Hyperferritinemic sepsis: in the HLH spectrum?

Scott L. Weiss, MD MSCE FCCM is an Associate Professor and Pediatric Intensivist at the University of Pennsylvania and Children’s Hospital of Philadelphia.  He completed medical school at Harvard, pediatric residency at Boston Children’s Hospital, and pediatric critical care fellowship at Northwestern/Lurie Children’s Hospital.  Dr. Weiss’ academic focus is pediatric sepsis, with his NIH-funded research focusing on the role of mitochondrial dysfunction in sepsis-induced immune dysregulation and organ dysfunction.  He is also active in studies of pediatric sepsis epidemiology and clinical trials to optimize sepsis recognition and resuscitation, and currently serves as the co-Vice Chair for the Pediatric Surviving Sepsis Campaign Taskforce. 


About the Society

The Histiocyte Society is a nonprofit organization of more than 200 physicians and scientists from around the world committed to improving the lives of patients with histiocytic disorders by conducting clinical and laboratory research into the causes and treatment of this disease.

Copyright © 2020 Histiocyte Society


Phone: +1 856 589 6606 
Fax: +1 856 589 6614
332 N Broadway
Pitman, NJ 08071 USA

Powered by Wild Apricot Membership Software